LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE597.054.1 (+0.69 %)
PREV CLOSE ( ) 592.95
OPEN PRICE ( ) 591.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 897
TODAY'S LOW / HIGH ( )590.95 601.70
52 WK LOW / HIGH ( )365.4 754.25
NSE600.357.05 (+1.19 %)
PREV CLOSE( ) 593.30
OPEN PRICE ( ) 598.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 600.35 (25)
VOLUME 18355
TODAY'S LOW / HIGH( ) 589.20 603.00
52 WK LOW / HIGH ( )365.25 755.15
Exchange
Year Open Price () High Price () Low Price () Close Price () Volume (000's) Value (lakhs)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.